In lung cancer, granulocyte-macrophage colony-stimulating factor (GM-CSF) derived from tumor cells activated STAT5 signaling, which transcriptionally upregulated fatty acid transport protein 2 (FATP2) expression in PMN-MDSCs. The gene discussed is SLC27A2; the disease is neoplasm.